LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 83 filers reported holding LEAP THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,360 | -24.4% | 4,000,000 | 0.0% | 0.08% | -19.0% |
| Q4 2022 | $1,800 | -99.9% | 4,000,000 | 0.0% | 0.10% | -33.3% |
| Q3 2022 | $3,520,000 | -23.5% | 4,000,000 | 0.0% | 0.15% | -39.0% |
| Q2 2022 | $4,600,000 | -34.3% | 4,000,000 | 0.0% | 0.25% | -16.0% |
| Q1 2022 | $7,000,000 | -46.0% | 4,000,000 | 0.0% | 0.29% | -16.8% |
| Q4 2021 | $12,960,000 | -19.2% | 4,000,000 | 0.0% | 0.35% | -1.9% |
| Q3 2021 | $16,040,000 | +226.0% | 4,000,000 | +33.3% | 0.36% | +259.0% |
| Q2 2021 | $4,920,000 | -13.7% | 3,000,000 | 0.0% | 0.10% | -1.0% |
| Q1 2021 | $5,700,000 | -15.6% | 3,000,000 | 0.0% | 0.10% | -30.3% |
| Q4 2020 | $6,750,000 | +20.7% | 3,000,000 | +6.2% | 0.14% | +6.6% |
| Q3 2020 | $5,594,000 | -10.0% | 2,825,300 | -5.0% | 0.14% | -21.8% |
| Q2 2020 | $6,216,000 | +1473.7% | 2,974,000 | +1089.6% | 0.17% | +923.5% |
| Q1 2020 | $395,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 476,223 | $533,000 | 0.13% |
| 683 Capital Management, LLC | 150,142 | $168,000 | 0.02% |
| Alyeska Investment Group, L.P. | 514,285 | $576,000 | 0.01% |
| Baker Brothers Advisors | 978,454 | $1,096,000 | 0.01% |
| Quilter Plc | 50,000 | $56,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 80,319 | $90,000 | 0.00% |
| FMR LLC | 660,800 | $740,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Lionsbridge Wealth Management LLC | 181 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 328,986 | $368,000 | 0.00% |